These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33006785)
1. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma. Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma. Pan J; Xu L; Pan H Front Oncol; 2020; 10():1444. PubMed ID: 32974164 [No Abstract] [Full Text] [Related]
3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
4. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma. Chen D; Guo W; Yu H; Yang J Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271 [TBL] [Abstract][Full Text] [Related]
5. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer. Lu X; Li R; Ying Y; Zhang W; Wang W J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934 [TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma. Liu T; Li C; Jin L; Li C; Wang L Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961 [TBL] [Abstract][Full Text] [Related]
7. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis. Miao C; Fang X; Chen Y; Zhao Y; Guo Q Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221 [TBL] [Abstract][Full Text] [Related]
8. A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma. Zhang X; Pang X; Huang Y; Qian S Medicine (Baltimore); 2021 Jul; 100(29):e26648. PubMed ID: 34398021 [TBL] [Abstract][Full Text] [Related]
9. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma. Zhen L; Pan W Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046 [TBL] [Abstract][Full Text] [Related]
10. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma. Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760 [TBL] [Abstract][Full Text] [Related]
11. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma. Li F; Zhang P Comput Math Methods Med; 2021; 2021():8715823. PubMed ID: 34840598 [TBL] [Abstract][Full Text] [Related]
12. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer. Ma J; Yang D; Ma XX Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220 [TBL] [Abstract][Full Text] [Related]
13. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
14. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879 [TBL] [Abstract][Full Text] [Related]
15. Effects of m6A RNA methylation regulators on endometrial cancer. Zhang Y; Yang Y J Clin Lab Anal; 2021 Sep; 35(9):e23942. PubMed ID: 34347888 [TBL] [Abstract][Full Text] [Related]
16. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer. Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521 [TBL] [Abstract][Full Text] [Related]
17. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network. Dong Y; Wen W; Yuan T; Liu L; Li X Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma. Wu X; Zhang X; Tao L; Dai X; Chen P Biomed Res Int; 2020; 2020():2053902. PubMed ID: 32733931 [TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma. Tian Q; Huang J; Zhang Q; Zhao J Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464 [TBL] [Abstract][Full Text] [Related]
20. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma. Shen C; Liu J; Yang X; Jiao W; Wang Y Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]